Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Capital Employed (2016 - 2025)

Fennec Pharmaceuticals' Return on Capital Employed history spans 15 years, with the latest figure at 0.03% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 9.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Dec 2025, down 9.0%, and an annual FY2025 reading of 0.03%, down 12.0% over the prior year.
  • Return on Capital Employed for Q4 2025 was 0.03% at Fennec Pharmaceuticals, up from 0.13% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.16% in Q1 2024, with the low at 1.42% in Q2 2023.
  • Average Return on Capital Employed over 5 years is 0.57%, with a median of 0.67% recorded in 2021.
  • Year-over-year, Return on Capital Employed crashed -50bps in 2022 and then surged 152bps in 2024.
  • Tracing FENC's Return on Capital Employed over 5 years: stood at 0.65% in 2021, then plummeted by -44bps to 0.94% in 2022, then increased by 14bps to 0.8% in 2023, then soared by 107bps to 0.06% in 2024, then tumbled by -154bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for FENC's Return on Capital Employed are 0.03% (Q4 2025), 0.13% (Q3 2025), and 0.26% (Q2 2025).